Totrial (Tianjin) Technology Co., Ltd. has officially changed its name to Totrial (Tianjin) Medical Technology Group Co., Ltd. This is a major milestone in the company's deep cultivation of the medical technology field and its advancement to a higher stage of development.

Looking back on its development journey, the company has always adhered to the mission of "innovation-driven medical technology development," continuously striving in areas such as clinical trial informatization management and intelligent analysis of medical data. From launching a clinical trial management system with independent intellectual property rights to forming a product matrix covering the entire clinical research process, it has gradually grown into an industry-recognized technology enterprise, thanks to the support of partners and clients.

This renaming is based on long-term strategic development planning. The term "Group" signifies the company's leapfrog development in business layout, team size, and resource integration capabilities. In the future, the company will leverage a more sound organizational structure and stronger technical capabilities to build a diversified and comprehensive medical technology service ecosystem. It will integrate resources such as clinical trials, medical big data, and artificial intelligence technology to provide one-stop solutions from R&D to application, promoting industrial collaborative development.

After the name change, all original business relationships, service commitments, and contract terms remain unchanged. Rights and obligations will be inherited by the new company. Official websites, social media accounts, and other platforms will be gradually updated. However, the passion and determination to provide high-quality services to clients remain unwavering. The company will continue to increase investments, optimize products and services, and looks forward to exploring new opportunities with more partners, creating new value, and writing a new chapter in the medical technology field.